Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The test involves collecting a small blood sample, usually through a finger prick or venous draw, and testing it for malaria antigens.
Rapid diagnostic tests (RDTs) can detect antigens specific to Plasmodium falciparum, Plasmodium vivax, or both, depending on the test used.
Yes, RDTs are generally reliable for detecting malaria antigens, with high specificity and sensitivity when performed correctly.
Some RDTs can differentiate between P. falciparum and other malaria species, aiding in targeted treatment strategies.
The test involves a simple blood draw with minimal risks, such as minor bruising at the puncture site.
Preventive health care involves measures taken to prevent diseases or conditions before they start. This includes regular check-ups, screenings, and vaccinations.
Common chronic diseases managed include diabetes, hypertension (high blood pressure), asthma, arthritis, and heart disease.
The frequency of health check-ups depends on your age, health status, and risk factors. Generally, adults should have a check-up at least once a year.
Women’s health services include gynaecological exams, prenatal care, family planning, breast health screenings, and menopause management.
Paediatric care includes well-child visits, vaccinations, developmental screenings, and management of childhood illnesses and conditions.
A positive result indicates recent or current infection with the Dengue virus.
No, additional tests, such as Dengue NS1 antigen test or PCR, may be required to identify the specific serotype.
No, the Dengue IgM test is designed to detect recent or current infections during the acute phase.
Dengue IgM antibodies are typically detectable in the bloodstream for up to 3 months after infection.
A negative result suggests no detectable Dengue IgM antibodies. If symptoms persist or there is recent exposure, consult a healthcare provider for further evaluation.